SynthesisClinical and experimental medicine2026
Sodium-glucose cotransporter-2 inhibitors and gastrointestinal neoplasm risk in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.
Yu-Fan Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.